C0014432||inhibitors
C0002003||aldose reductase
C0002003||ALR2
C0032405||poly (ADP-ribose) polymerase
C0032405||PARP-1
C0678594||structure
C0008972||Clinical studies
C0011884||diabetic retinopathy
C0012634||disorder
C0002003||ALR2
C0032405||PARP-1
C0035298||retinal
C0007634||cells
C0087111||treatment
C0011884||diabetic retinopathy
C0014432||inhibitors
C0002003||ALR2
C0032405||PARP-1
C0678594||structure
C0033684||proteins
C1568506||thiazolidine-2,4-dione
C1568506||thiazolidine-2,4-dione
C1152555||inhibitory activities
C0002003||ALR2
C0032405||PARP-1
C2825142||experimental results
C1254351||compounds 5b
C1254351||5f
C0014442||enzymes
C0014432||inhibitors
C0014442||enzymes
C1167622||binding
C0014432||inhibitors
C0014442||enzymes
C1446409||positive
C0005507||assay
C1254351||compounds
C0087111||treatment
C0011884||diabetic retinopathy